Cellyan Biotechnology Co., Ltd Current Restricted Cash And Cash Equivalents
Cellyan Biotechnology Co., Ltd (HKPD) had Current Restricted Cash And Cash Equivalents of $459 as of 2025-09-30, per its 6-K filed 2026-03-18.
Financial Statements › Notes
ifrs-full:CurrentRestrictedCashAndCashEquivalents · last filed 2026-03-18
- 2025-09-30: Current Restricted Cash And Cash Equivalents $459.00.
- 2025-03-31: Current Restricted Cash And Cash Equivalents $400.00.
- 2024-03-31: Current Restricted Cash And Cash Equivalents $7.68K.
| Period end | Current Restricted Cash And Cash Equivalents |
|---|---|
| 2025-09-30 | $459.00 6-K · filed 2026-03-18 |
| 2025-03-31 | $400.00 6-K · filed 2026-03-18 |
| 2024-03-31 | $7.68K 20-F · filed 2025-08-14 |